June 20th, 2023

Raytheon Missiles & Defense, a business segment of RTX (NYSE: RTX), has been awarded a significant contract worth $1,151,111,454 for the production of Advanced Medium Range Air-to-Air Missiles (AMRAAM). The contract also includes the provision of AMR. Read more

June 20th, 2023

Shares of PureCycle Technologies, Inc. (Nasdaq: PCT) experienced a significant surge of over 10% in after-hours trading Tuesday following the successful production of the first run of Ultra-Pure Recycled (UPR) resin from post-industrial recycled mate. Read more

June 20th, 2023

Company’s self-reporting and additional cooperation result in partial declination of charges and no civil penalty FOR IMMEDIATE RELEASE 2023-111 Washington D.C. / CRWE PRESS RELEASE / June 20, 2023  — The Securities and Exchan. Read more

June 20th, 2023

MiMedx Group, Inc. (Nasdaq: MDXG) has announced a strategic realignment aimed at prioritizing the growth of its Wound & Surgical business.  This realignment involves the immediate suspension of its Knee Osteoarthritis program and the disbandi. Read more

June 20th, 2023

Nuwellis, Inc. (Nasdaq: NUWE) has partnered with DaVita Inc. (NYSE: DVA) through a Supply and Collaboration Agreement to introduce Aquadex ultrafiltration therapy for the treatment of adult patients with congestive heart failure in select U.S. market. Read more

June 20th, 2023

Philip Morris International Inc. (NYSE: PM), a global tobacco company, was upgraded from Neutral to Buy by Citigroup, with the price target raised from $109 to $117.  On Friday, $PM closed at $94.89, indicating a potential upside of $22.11 or. Read more

June 20th, 2023

Shares of Sanofi (Nasdaq: SNY) surged in pre-market trading following the announcement of a favorable outcome in an International Chamber of Commerce dispute.  The tribunal ruled in favor of Sanofi, dismissing Boehringer Ingelheim's. Read more

June 20th, 2023

Tesla, Inc. (Nasdaq: TSLA), a renowned electric vehicle and clean energy company, is increasing the protection of its intellectual property with two new patents awarded by The United States Patent and Trademark Office (USPTO). The first patent, No. Read more

June 20th, 2023

Arcellx, Inc. (Nasdaq: ACLX) said that its CART-ddBCMA investigational new drug (IND) for the treatment of relapsed or refractory multiple myeloma (rrMM) has been placed on clinical hold by the U.S. Food and Drug Administration (FDA).  The cl. Read more

June 19th, 2023

United States Steel Corporation (NYSE: X) has provided guidance for the second quarter of 2023, stating that its adjusted net earnings per diluted share are expected to be in the range of $1.81 to $1.86. This surpasses the consensus estimate of $1.76. Read more